MarketCap
Facebook
X
Telegram
Aspira Women's Health ROCE Ratio | AWH
Annual ROCE Ratio Aspira Women's Health
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114.15 | 635.12 | 797.12 | -446.17 | -108.03 | -136.17 | -155.11 | -134.21 | -213.6 | -273.98 | -109.31 | -99.77 | -32.73 | -173.15 | -151.62 | -316.33 | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 797.12 | -446.17 | -50.24 |
Quarterly ROCE Ratio Aspira Women's Health
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5539.25 | 5652.33 | 5734.42 | 6012.57 | 612.57 | 1237.16 | 1906.96 | 1029.14 | 683.58 | 606.82 | -75.96 | -936.86 | -177.49 | -202.66 | -143.14 | -96.18 | -53.65 | -97.7 | -111.9 | -133.76 | -122.51 | -166.57 | -171.79 | -174.99 | -135.89 | -172.84 | -171.16 | -161.53 | -118.97 | -192.32 | -224.23 | -259.8 | -220.16 | -312.27 | -338.89 | -400.18 | -322.22 | -351.53 | -287.06 | -211.38 | -81.23 | -110.26 | -109.81 | -102.93 | -78.64 | -87.3 | -66.19 | -47.04 | -26.29 | -75.53 | -145.54 | -183.99 | -174.27 | -217.97 | -222.76 | -187.03 | -140.66 | -43.7 | -54.03 | -42.93 |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 6012.57 | -936.86 | 337.85 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Fulgent Genetics
FLGT
|
-8.03 | $ 25.83 | -1.22 % | $ 795 M |  USA |
 |
CareDx, Inc
CDNA
|
-9.52 | $ 80.78 | -4.31 % | $ 4.3 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
Biomerica
BMRA
|
-202.28 | $ 1.48 | -4.52 % | $ 4.31 M | USA |
 |
Interpace Biosciences
IDXG
|
18.26 | $ 7.0 | -13.43 % | $ 31 M | USA |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
ICON Public Limited Company
ICLR
|
3.39 | $ 204.62 | -1.43 % | $ 16 B |  Irlanda |
 |
Co-Diagnostics
CODX
|
-236.6 | $ 0.29 | -9.5 % | $ 386 K | USA |
 |
Burning Rock Biotech Limited
BNR
|
-9.56 | $ 13.19 | 6.46 % | $ 135 M |  China |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
DarioHealth Corp.
DRIO
|
-36.38 | $ 2.37 | 15.05 % | $ 9.44 M |  Israel |
 |
Myriad Genetics
MYGN
|
-67.6 | $ 5.66 | -1.39 % | $ 524 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-185.74 | $ 4.78 | -1.24 % | $ 3.76 M | USA |
 |
QIAGEN N.V.
QGEN
|
8.07 | $ 50.52 | -0.07 % | $ 11 B |  Niderland |
 |
NeoGenomics
NEO
|
-9.11 | $ 16.97 | -3.58 % | $ 2.17 B | USA |
 |
OPKO Health
OPK
|
-6.58 | $ 1.71 | 0.58 % | $ 1.28 B | USA |
 |
Pacific Biosciences of California
PACB
|
-77.87 | $ 2.22 | -5.93 % | $ 666 M | USA |
 |
Neogen Corporation
NEOG
|
-1.03 | $ 11.67 | -3.44 % | $ 2.54 B | USA |
 |
Precipio
PRPO
|
-6.84 | $ 23.56 | 6.13 % | $ 37.8 M | USA |
 |
Personalis
PSNL
|
-29.9 | $ 15.9 | -0.31 % | $ 1.42 B | USA |
 |
Sotera Health Company
SHC
|
10.33 | $ 16.25 | -1.16 % | $ 4.61 B | USA |
 |
Quidel Corporation
QDEL
|
69.35 | $ 11.56 | -4.43 % | $ 487 M | USA |
 |
Centogene N.V.
CNTG
|
-87.78 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Trinity Biotech plc
TRIB
|
-29.73 | $ 5.88 | 10.08 % | $ 2.11 B | Irlanda |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-119.91 | - | 0.12 % | $ 80.1 M | China |
 |
Check-Cap Ltd.
CHEK
|
-69.04 | - | - | $ 9.42 M | Israel |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | USA |
 |
National Research Corporation
NRC
|
22.99 | $ 26.91 | 0.9 % | $ 602 M | USA |
 |
Twist Bioscience Corporation
TWST
|
-28.81 | $ 132.17 | -2.35 % | $ 7.9 B | USA |
 |
Organovo Holdings
ONVO
|
1045.22 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
75.43 | - | -16.95 % | $ 1.54 M | USA |
 |
PerkinElmer
PKI
|
3.29 | - | -0.91 % | $ 14.7 B | USA |
 |
Soleno Therapeutics
SLNO
|
1.87 | - | - | $ 2.69 B | USA |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
Waters Corporation
WAT
|
7.05 | $ 476.29 | -0.09 % | $ 28.4 B | USA |
 |
Exagen
XGN
|
-32.08 | $ 5.26 | -25.92 % | $ 113 M | USA |
 |
Celcuity
CELC
|
-40.76 | $ 67.13 | -4.11 % | $ 3.14 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
8.9 | $ 370.89 | -0.25 % | $ 30.9 B | USA |
 |
Lantheus Holdings
LNTH
|
16.41 | $ 101.65 | 0.63 % | $ 6.86 B | USA |
 |
Accelerate Diagnostics
AXDX
|
63.01 | - | -61.36 % | $ 2.46 M | USA |
 |
Medpace Holdings
MEDP
|
116.53 | $ 664.97 | -1.18 % | $ 19.2 B | USA |
 |
Charles River Laboratories International
CRL
|
0.42 | $ 346.21 | -2.02 % | $ 17.2 B | USA |
 |
Mettler-Toledo International
MTD
|
35.8 | $ 1 750.2 | -0.69 % | $ 36.1 B |  Schweiz |
 |
Danaher Corporation
DHR
|
8.93 | $ 236.19 | 0.46 % | $ 168 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
7.33 | $ 30.39 | -1.32 % | $ 28.8 B | Niderland |
 |
RadNet
RDNT
|
2.13 | $ 77.91 | -0.6 % | $ 5.86 B | USA |
 |
Senseonics Holdings
SENS
|
-67.05 | $ 10.05 | 2.55 % | $ 419 M | USA |